| Product | Division | Sales |
|---|---|---|
| € million | ||
| Yasmin®/ YAZ®/ Yasminelle® |
Bayer Schering Pharma | 1,222 |
| Betaferon®/Betaseron® | Bayer Schering Pharma | 1,144 |
| Kogenate® | Bayer Schering Pharma | 848 |
| Adalat® | Bayer Schering Pharma | 626 |
| Contour® | Diabetes Care |
554 |
| Aspirin® * |
Consumer Care | 499 |
| Avalox®/Avelox® | Bayer Schering Pharma | 462 |
| Nevaxar® | Bayer Schering Pharma | 462 |
| Mirena® | Bayer Schering Pharma | 462 |
| Levitra® | Bayer Schering Pharma | 341 |
| Cipro®/Ciprobay® |
Bayer Schering Pharma | 338 |
| Advantage®-Product line |
Animal Health |
329 |
| Glucobay® | Bayer Schering Pharma | 304 |
| Aspirin Cardio® * |
Bayer Schering Pharma | 270 |
| Ultravist® |
Bayer Schering Pharma | 261 |
| Magnevist® | Bayer Schering Pharma | 241 |
| Aleve®/ Naproxen |
Consumer Care | 220 |
| Canesten® | Consumer Care | 200 |
| Iopamiron® | Bayer Schering Pharma | 199 |
| Bepanthen® / Bepanthenol® | Consumer Care | 173 |
* total Aspirin® sales = 719 million (2007: 689 million), including Aspirin Cardio®, which is reflected in sales of the Pharmaceuticals segment